Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Castillo

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
ERJ Open Research|February 27, 2024
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort studyEsteban Cano-Jiménez, Ana Villar Gómez, Eduardo Velez Segovia, et al.
Archivos De Bronconeumologia|April 25, 2021
Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital CapacityGuadalupe Bermudo, Guillermo Suarez-Cuartin, Pilar Rivera-Ortega, et al.
Open Respiratory Archives|July 18, 2024
[Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery]Myriam Aburto, José Antonio Rodríguez-Portal, Estrella Fernandez-Fabrellas, et al.
The European Respiratory Journal|March 28, 2025
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trialGuadalupe Bermudo-Peloche, Belén Del Rio, Vanesa Vicens-Zygmunt, et al.
Respirology (Carlton, Vic.)|November 9, 2020
Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggersJessica Germaine Shull, Maria Teresa Pay, Carla Lara Compte, et al.
Frontiers in Epidemiology|July 2, 2024
Multiple sclerosis in Central America and Caribbean countries: frequency and clinical characterization of an emergent diseaseFernando Gracia, Deyanira A Ramírez Navarro, Nicia E Ramírez Sánchez, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
ERJ Open Research|February 27, 2024
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort studyEsteban Cano-Jiménez, Ana Villar Gómez, Eduardo Velez Segovia, et al.
Archivos De Bronconeumologia|April 25, 2021
Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital CapacityGuadalupe Bermudo, Guillermo Suarez-Cuartin, Pilar Rivera-Ortega, et al.
Open Respiratory Archives|July 18, 2024
[Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery]Myriam Aburto, José Antonio Rodríguez-Portal, Estrella Fernandez-Fabrellas, et al.
The European Respiratory Journal|March 28, 2025
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trialGuadalupe Bermudo-Peloche, Belén Del Rio, Vanesa Vicens-Zygmunt, et al.
Respirology (Carlton, Vic.)|November 9, 2020
Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggersJessica Germaine Shull, Maria Teresa Pay, Carla Lara Compte, et al.
Frontiers in Epidemiology|July 2, 2024
Multiple sclerosis in Central America and Caribbean countries: frequency and clinical characterization of an emergent diseaseFernando Gracia, Deyanira A Ramírez Navarro, Nicia E Ramírez Sánchez, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
Pageof 12